Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug 26;5(9):e635.
doi: 10.1097/HS9.0000000000000635. eCollection 2021 Sep.

The EHA Research Roadmap: Malignant Myeloid Diseases

Hartmut Döhner  1 , Luca Malcovati  2 , Gert J Ossenkoppele  3 , Andreas Hochhaus  4 , Alessandro Maria Vannucchi  5 , Lars Bullinger  6   7 , Francisco Cervantes  7 , Charles Craddock  8 , Theo de Witte  9 , Konstanze Döhner  1 , Hervé Dombret  10 , Pierre Fenaux  11 , Jan Geissler  12 , Ulrich Germing  13 , Francois Guilhot  14 , Claire Harrison  15 , Eva Hellström-Lindberg  16 , Francesco Passamonti  17 , Jorge Sierra  18 , Radek Skoda  19 , Agnieszka Wierzbowska  20
Affiliations
Editorial

The EHA Research Roadmap: Malignant Myeloid Diseases

Hartmut Döhner et al. Hemasphere. .
No abstract available

PubMed Disclaimer

References

    1. Engert A, Balduini C, Brand A, et al. . The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica. 2016;101:115–208. - PMC - PubMed
    1. Delhommeau F, Dupont S, Della Valle V, et al. . Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360:2289–2301. - PubMed
    1. Papaemmanuil E, Cazzola M, Boultwood J, et al. . Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384–1395. - PMC - PubMed
    1. Papaemmanuil E, Gerstung M, Malcovati L, et al. . Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616–3627. - PMC - PubMed
    1. Malcovati L, Stevenson K, Papaemmanuil E, et al. . SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136:157–170. - PMC - PubMed

Publication types